Adamis Pharmaceuticals Corporation logo
Adamis Pharmaceuticals Corporation ADMP

Quartalsbericht 2023-Q3
hinzugefügt 14.11.2023

report update icon

Adamis Pharmaceuticals Corporation EV 2011-2026 | ADMP

EV Jährlich Adamis Pharmaceuticals Corporation

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
28.5 M 75.7 M 81.8 M 38.7 M 113 M 98 M 62.7 M 61.7 M 39 M 54.5 M 61 M 16.5 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
113 M 16.5 M 60.9 M

EV anderer Aktien in der Arzneimittelhersteller

Name EV Preis % 24h Marktkapitalisierung Land
AcelRx Pharmaceuticals AcelRx Pharmaceuticals
ACRX
6.79 M - 7.5 % $ 6.35 M usaUSA
Alimera Sciences Alimera Sciences
ALIM
197 M - - $ 142 M usaUSA
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
737 M - - $ 754 M usaUSA
Agile Therapeutics Agile Therapeutics
AGRX
25.3 M - 10.11 % $ 58.2 M usaUSA
Aurora Cannabis Aurora Cannabis
ACB
106 M $ 3.32 0.3 % $ 86.3 M canadaCanada
China Pharma Holdings China Pharma Holdings
CPHI
11.1 M $ 0.57 -9.62 % $ 9.95 M chinaChina
Catalent Catalent
CTLT
16.7 B - - $ 11.5 B usaUSA
Athenex Athenex
ATNX
209 M - -23.39 % $ 1.76 M usaUSA
Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc
AVDL
756 M - - $ 2.06 B franceFrance
Cronos Group Cronos Group
CRON
3.84 B $ 2.58 2.38 % $ 1.34 B canadaCanada
DURECT Corporation DURECT Corporation
DRRX
3.37 M - - $ 50.1 M usaUSA
Emergent BioSolutions Emergent BioSolutions
EBS
1.2 B $ 8.01 -0.5 % $ 410 M usaUSA
Endo International plc Endo International plc
ENDP
-710 M - - $ 28.9 M irlandaIrlanda
Evoke Pharma Evoke Pharma
EVOK
7.15 M - - $ 36.6 M usaUSA
Pacira BioSciences Pacira BioSciences
PCRX
1.68 B $ 23.2 2.43 % $ 1.07 B usaUSA
Calliditas Therapeutics AB (publ) Calliditas Therapeutics AB (publ)
CALT
10.2 M - -0.1 % $ 2.03 B schwedenSchweden
HEXO Corp. HEXO Corp.
HEXO
284 M - 2.45 % $ 38.1 M canadaCanada
Cumberland Pharmaceuticals Cumberland Pharmaceuticals
CPIX
124 M $ 3.13 2.62 % $ 44 M usaUSA
Bausch Health Companies Bausch Health Companies
BHC
29.9 B $ 4.99 -2.25 % $ 1.82 B canadaCanada
Perrigo Company plc Perrigo Company plc
PRGO
7.03 B $ 9.64 0.73 % $ 1.34 B usaUSA
Harrow Health Harrow Health
HROW
2.21 B $ 35.2 3.53 % $ 1.29 B usaUSA
OptiNose OptiNose
OPTN
312 M - - $ 1.08 B usaUSA
Evolus Evolus
EOLS
467 M $ 4.43 -5.34 % $ 286 M usaUSA
Rockwell Medical Rockwell Medical
RMTI
57.3 M $ 1.03 0.98 % $ 24 M usaUSA
SCYNEXIS SCYNEXIS
SCYX
26.3 M $ 0.9 2.8 % $ 44.9 M usaUSA
Solid Biosciences Solid Biosciences
SLDB
616 M $ 6.68 -6.44 % $ 585 M usaUSA
Sundial Growers Sundial Growers
SNDL
-17.5 M $ 1.37 0.74 % $ 3.37 M canadaCanada
Sonoma Pharmaceuticals Sonoma Pharmaceuticals
SNOA
7.57 M $ 2.34 -8.24 % $ 2.9 M usaUSA
Eagle Pharmaceuticals Eagle Pharmaceuticals
EGRX
457 M - -39.89 % $ 27.7 M usaUSA
Relmada Therapeutics Relmada Therapeutics
RLMD
251 M $ 6.1 4.1 % $ 241 M usaUSA
Tilray Tilray
TLRY
1.96 B $ 6.66 3.26 % $ 4.12 B canadaCanada
OrganiGram Holdings OrganiGram Holdings
OGI
456 M $ 1.34 -1.47 % $ 402 M canadaCanada
PetIQ PetIQ
PETQ
280 M - 1.64 % $ 400 M usaUSA
PLx Pharma PLx Pharma
PLXP
73.8 M - -27.8 % $ 2.56 M usaUSA
ProPhase Labs ProPhase Labs
PRPH
145 M - - $ 5.07 M usaUSA
Veru Veru
VERU
111 M $ 2.29 -0.43 % $ 309 M usaUSA
Jupiter Wellness Jupiter Wellness
JUPW
91.9 M - - $ 33.6 M usaUSA
TherapeuticsMD TherapeuticsMD
TXMD
33.6 M $ 2.29 -0.87 % $ 23.9 M usaUSA
Viatris Viatris
VTRS
41.3 B $ 13.36 0.53 % $ 16 B usaUSA
Radius Health Radius Health
RDUS
700 M - - $ 1.42 B usaUSA
Lannett Company Lannett Company
LCI
648 M - 1.15 % $ 7.11 M usaUSA
cbdMD cbdMD
YCBD
7.85 M $ 0.77 1.06 % $ 3.32 M usaUSA
Organogenesis Holdings Organogenesis Holdings
ORGO
392 M $ 2.41 -2.43 % $ 317 M usaUSA
Neoleukin Therapeutics Neoleukin Therapeutics
NLTX
-110 M - - $ 193 M canadaCanada
Canopy Growth Corporation Canopy Growth Corporation
CGC
459 M $ 0.96 -0.87 % $ 103 M canadaCanada
Assertio Holdings Assertio Holdings
ASRT
238 M $ 16.51 17.93 % $ 106 M usaUSA
Recro Pharma Recro Pharma
REPH
220 M - -4.76 % $ 65.3 M usaUSA
Tricida Tricida
TCDA
506 M - - $ 3.25 M usaUSA
Zynerba Pharmaceuticals Zynerba Pharmaceuticals
ZYNE
-22.6 M - - $ 55.5 M usaUSA